탈모를 예방하는 과학적으로 증명된 습관이 있을까?

No robust lifestyle intervention has been proven to prevent male-pattern (androgenetic) alopecia. Current evidence supports pharmacologic prevention/early treatment rather than diet or lifestyle changes as the primary strategy.[1]

Pharmacologic prevention in high-risk men

Men with a strong family history of AGA or visible thinning before age 30 are considered highest risk, and early initiation of topical minoxidil is considered a relatively safe method to slow progression.[1] Off-label preventive use of oral finasteride is increasingly common in practice, though it is not currently endorsed by formal guidelines for prevention (only for established AGA).[1] Once AGA is present, FDA-approved options with strong trial support include topical minoxidil (2% or 5% solution/foam) and oral finasteride 1 mg daily, both shown in meta-analyses to significantly increase hair density versus placebo.[2][3] Oral dutasteride 0.5 mg and higher-dose oral minoxidil (5 mg) have shown even greater efficacy than standard finasteride/minoxidil regimens in a network meta-analysis, though dutasteride is not FDA-approved for this indication.[4][5] Low-level laser light therapy is FDA-cleared and has modest but statistically significant benefit.[2][3]

Below is the network meta-analysis heatmap comparing these interventions across hair count outcomes at 24 and 48 weeks.

 

Sexual adverse effects have been reported with finasteride/dutasteride (5α-reductase inhibitors), including changes in libido, ejaculation, and orgasm that in some cases persisted after discontinuation; these agents can also lower serum PSA, which matters for prostate cancer screening interpretation.[2][4]

 

Lifestyle and dietary factors

Direct evidence for lifestyle modification preventing AGA is currently lacking. A 2025 Nature Reviews Disease Primers review explicitly states no evidence exists for dietary or lifestyle changes preventing AGA and calls for adequately powered studies.[1] A separate literature review has examined associations between AGA and diet, sleep, ultraviolet exposure, exercise, and hairstyling practices, proposing plausible mechanistic links (e.g., oxidative stress, microvascular changes), but this is hypothesis-generating rather than proof of prevention.[6] A 2026 clinical review similarly found that nutritional supplements, nutraceuticals, and other adjunctive/lifestyle measures show only modest benefit at best, with significant methodological limitations across studies (small samples, heterogeneous designs, lack of long-term safety data).[7]

Given this, the only interventions with reasonably strong, reproducible evidence remain topical minoxidil, oral/topical finasteride, and (secondarily) low-level laser therapy — not general lifestyle changes.[2][4][3][5]

---

 

References

1. Androgenetic alopecia. Liu Y, Tosti A, Wang ECE, et al. Nature Reviews. Disease Primers. 2025;11(1):73. doi:10.1038/s41572-025-00656-9.
2. Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021. Mirmirani P, Fu J. JAMA. 2021;325(9):878-879. doi:10.1001/jama.2020.19313.
3. The Effectiveness of Treatments for Androgenetic Alopecia: A Systematic Review and Meta-Analysis. Adil A, Godwin M. Journal of the American Academy of Dermatology. 2017;77(1):136-141.e5. doi:10.1016/j.jaad.2017.02.054.
4. What’s New in Therapy for Male Androgenetic Alopecia?. Saceda-Corralo D, Domínguez-Santas M, Vañó-Galván S, Grimalt R. American Journal of Clinical Dermatology. 2023;24(1):15-24. doi:10.1007/s40257-022-00730-y.
5. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients. Gupta AK, Venkataraman M, Talukder M, Bamimore MA. JAMA Dermatology. 2022;158(3):266-274. doi:10.1001/jamadermatol.2021.5743.
6. Lifestyle Factors Affecting the Pathogenesis of Androgenetic Alopecia: A Literature Review. Huang F, Tang L, Zhou X, Fu Q, Lu Y. Frontiers in Public Health. 2026;14:1739298. doi:10.3389/fpubh.2026.1739298.
7. Adjunctive Approaches for Androgenetic Alopecia: A Clinical Review of Nutritional, Light-Based, Topical, and Lifestyle Interventions. Podolsky AS, Iorizzo M, Lo Sicco KI, et al. Journal of the American Academy of Dermatology. 2026;95(1):148-161. doi:10.1016/j.jaad.2026.03.061.